Keywords

nanomedicine; theranostics; cancer; bioimaging; superparamagnetic; core-shell nanoparticles

Abstract

This study presents the synthesis and comprehensive characterization of a novel core-shell nanoparticle composed of a maghemite (γ-Fe2O3) core and a europium-doped cerium oxide (EuCNP) shell, developed for potential use in cancer theranostics. Using a co-precipitation method, Fe2O3–EuCNP core-shell nanoparticles were synthesized and compared against control samples of CNPs, EuCNPs, and Fe2O3. A variety of characterization techniques, including UV-Vis spectroscopy, fluorescence spectroscopy, TEM, XRD, XPS, DLS, TGA, and DSC confirmed the successful synthesis of core-shell architecture and europium doping. Moreover, Fe2O3–EuCNPs demonstrating strong colloidal stability (high zeta potential), enhanced Ce3+ content, and enhanced photoluminescence. RAW 264.7 macrophages cells showed good cell viability after incubating with the nanoparticles, while MCF-7 breast cancer cells showed relatively greater cell death. The multifunctionality of these nanoparticles—combining magnetic, antioxidant, and fluorescent properties—positions them as promising candidates for future development in magnetic hyperthermia treatment, magnetic drug targeting, and optical imaging in cancer therapy.

Thesis Completion Year

2025

Thesis Completion Semester

Spring

Thesis Chair

Seal, Sudipta

College

College of Engineering and Computer Science

Department

Materials Science and Engineering; Burnett School of Biomedical Sciences

Thesis Discipline

Nanomedicine

Language

English

Access Status

Open Access

Length of Campus Access

None

Campus Location

Orlando (Main) Campus

Share

COinS
 

Rights Statement

In Copyright